5[2]Authors/Task Force Members:2007 Guidelines for the Management of Arterial Hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC) J Hypertension,2007,25:1105-1187
6[3]The ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or diuretic:The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT).JAMA,2002,288:2981-2997
7[4]Franz HM,Staessen JA.Amlodipine Better Than Lisinopril?:How One Randomized Clinical Trial Ended Fallacies From Observational Studies.Hypertension,2006,48:359-361
8[5]Nissen SE,Tuzcu EM,Libby P,et al.CAMELOT Investigators.Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study:a randomized controlled trial.JAMA,2004,292:2217-2225
9[6]Dahlof B,Sever PS,Poulter NR,et al.ASCOT Investigators.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendoflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):A multicenter randomized controlled trial.Lancet,2005,366:895-906
10[7]Pahor M,Psaty BM,Alderman MH,et al.Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.Diabetes Care,2000,23:888-892
